Quercetin 3-O-glucoside suppresses epidermal growth factor–induced migration by inhibiting EGFR signaling in pancreatic cancer cells

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Flavonoid Quercetin Inhibits Pancreatic Cancer Growth In Vitro and In Vivo

(2012) Eliane Angst et al.   PANCREAS

The proto-oncogene c-src is involved in primordial follicle activation through the PI3K, PKC and MAPK signaling pathways

(2012) Xiao-Yu Du et al.   Reproductive Biology and Endocrinology

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)

(2011) E. Aranda et al.   ANNALS OF ONCOLOGY

The flavonoid quercetin in disease prevention and therapy: Facts and fancies

(2011) Maria Russo et al.   BIOCHEMICAL PHARMACOLOGY

Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival

(2011) Jungwhoi Lee et al.   CANCER LETTERS

Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT

(2011) Jungwhoi Lee et al.   CANCER LETTERS

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma

(2011) Carla Cano et al.   TheScientificWorldJOURNAL

Epidermal Growth Factor Receptor in Pancreatic Cancer

(2011) Melissa Oliveira-Cunha et al.   Cancers

Quercetin and Cancer Chemoprevention

(2010) Lara Gibellini et al.   Evidence-based Complementary and Alternative Medicine

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

Multitargeted cancer prevention by quercetin

(2008) Akira Murakami et al.   CANCER LETTERS